Xing Lingzhi, Gong Yubowen, Liao GuoJia, Wang Liying, Chen Ling
Faculty of Pediatrics, Chongqing Medical University, Chongqing, China.
The Center of Experimental Teaching Management, Chongqing Medical University, Chongqing, China.
Diabetol Metab Syndr. 2025 Apr 18;17(1):130. doi: 10.1186/s13098-025-01688-7.
The prognostic value of Magnesium Depletion Score (MDS) in Diabetic Kidney Disease (DKD) patients is still unclear. This study aimed to determine the associations between MDS and long-term mortality in DKD population.
Data were obtained from the National Health and Nutrition Examination Survey (NHANES III). MDS is calculated from four specific scoring items: estimated glomerular filtration rate (eGFR), heavy drinking, use of proton pump inhibitors (PPI), and use of diuretics. Multivariate Cox proportional hazards regression models was employed to explore the association between MDS and all-cause and cause specific mortality, with emphasis on age-specific analysis.Mediation analysis explored if metabolic indices mediate the relation between MDS and mortality. Sensitive analyses were performed to check the robustness of the main findings.
3,179 patients with DKD were included in this study, with 1,698 females and 1,481 males. The multivariate Cox regression analyses showed higher MDS were significantly associated with the all-cause mortality of DKD population [MDS ≥ 3: adjusted hazard ratio (HR):1.932, 95% confidence interval (CI): 1.339-2.787,p < 0.001]. Meanwhile, the trend was also significant in cardiovascular mortality of the DKD population (MDS ≥ 3: HR = 3.688, 95%CI: 1.702-8.577,p < 0.001). Heavy drinking was the most influential factor among the four MDS scoring items that affects mortality outcomes. Mediation analysis showed increased MDS could slightly improve metabolic levels, but the improvement was insufficient to reverse the mortality outcome in DKD patients. Subgroup analysis manifested that the result was more applicable for patients over 60. The result of the sensitive analysis confirmed the robustness of the main conclusion.
Our study highlights the clinical prognostic value of MDS in predicting the survival of the DKD population, especially among patients over 60. The findings imply that reducing alcohol consumption and performing routine cardiovascular health assessments for DKD patients with MDS > 2 are important for prolonging DKD patients' survival time.
镁缺乏评分(MDS)在糖尿病肾病(DKD)患者中的预后价值仍不明确。本研究旨在确定MDS与DKD人群长期死亡率之间的关联。
数据来自国家健康和营养检查调查(NHANES III)。MDS由四个特定评分项目计算得出:估计肾小球滤过率(eGFR)、大量饮酒、使用质子泵抑制剂(PPI)和使用利尿剂。采用多变量Cox比例风险回归模型探讨MDS与全因死亡率和特定病因死亡率之间的关联,重点进行年龄特异性分析。中介分析探讨代谢指标是否介导MDS与死亡率之间的关系。进行敏感性分析以检验主要结果的稳健性。
本研究纳入了3179例DKD患者,其中女性1698例,男性1481例。多变量Cox回归分析显示,较高的MDS与DKD人群的全因死亡率显著相关[MDS≥3:调整后风险比(HR):1.932,95%置信区间(CI):1.339 - 2.787,p < 0.001]。同时,在DKD人群的心血管死亡率中该趋势也很显著(MDS≥3:HR = 3.688,95%CI:1.702 - 8.577,p < 0.001)。大量饮酒是影响死亡率结果的四个MDS评分项目中最具影响力的因素。中介分析表明,MDS升高可略微改善代谢水平,但改善程度不足以逆转DKD患者的死亡率结果。亚组分析表明,该结果更适用于60岁以上的患者。敏感性分析结果证实了主要结论的稳健性。
我们的研究突出了MDS在预测DKD人群生存方面的临床预后价值,尤其是在60岁以上的患者中。研究结果表明,减少饮酒以及对MDS>2的DKD患者进行常规心血管健康评估对于延长DKD患者的生存时间很重要。